Gravitas-119: A Single-Arm, Open-Label, Phase 1 Study Of Itacitinib In Combination With Calcineurin Inhibitor-Based Interventions For The Prophylaxis Of Graft Versus Host Dis-ease

Type of Cancer
Transplant

Phase

Division (Location)

Study ID

NCT#

Brief Description
Gravitas-119: A Single-Arm, Open-Label, Phase 1 Study Of Itacitinib In Combination With Calcineurin Inhibitor-Based Interventions For The Prophylaxis Of Graft Versus Host Dis-ease

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.